Skip To Main Content
Dan Gaita on Muck Rack

Dan Gaita

As seen in: heart, Diabetes Research and Clinical Practice
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Dan Gaita’s profile

Articles by Dan Gaita

Comprehensive imaging in patients with suspected pulmonary arterial hypertension

|
By Silvia Luca, Cristina Vacarescu, Dan Gaita, Simina Crisan
| heart Verified
Your Privacy We process your data to deliver content or advertisements and measure the delivery of such content or advertisements to extract insights about our website. We share this information with our partners on the basis of consent and legitimate interest. You may exercise your right to consent or object to a legitimate interest, based on a specific purpose below or at a partner level in the link under each purpose.
Open in Who Shared View Duplicates (7) Issue with article?

Adoption of the ADA/EASD guidelines in 10 Eastern and Southern European countries: physician survey and good clinical practice recommendations from an International Expert Panel

|
By Maciej Banach, Zielona Góra, Dan Gaita, Martin Haluzík Verified
| Diabetes Research and Clinical Practice Verified
Abstract Aims Evidence from cardiovascular outcomes trials (CVOTs) of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors was reflected in the most recent guidelines from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
Open in Who Shared Issue with article?

Non-HDL cholesterol series: PCSK9 inhibitor new season!

|
By Dan Gaita, Laura Gaita, Adelina Mihaescu
| Memory Studies
After a long and restless fight with “the evil” low-density lipoprotein (LDL) cholesterol, cardiologists discovered that the residual cardiovascular risk is still high, despite the achievement of dramatically decreased target levels of the LDL fraction of cholesterol with the statin, the beloved and multipotent drug.1 That is why the most recent European cardiovascular guidelines recommend targeting non-high-density lipoprotein (HDL) cholesterol levels, especially in patients with diabetes...
Open in Who Shared Issue with article?
|
By Hannah McGee, Werner Benzer, Bernhard Rauch, Jean-Paul Schmid, Ann Dorthe Zwisler, Paul Dendale, Constantinos H. Davos, Evangelia Koudi, Attila Simon, Ana Abreu, Nana Pogosova, Dan Gaita, Bojan Miletic, Gerd Bönner, Taoufik Ouarrak
| secure.jbs.elsevierhealth.com
Open in Who Shared Issue with article?
Show More